FREMONT, Calif., Sept. 5 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
(Nasdaq: PDLI) announced today that Mark McDade, Chief Executive Officer,
will present at the 2006 Newsmakers in the Biotech Industry Conference in
New York on Thursday, September 7, 2006 at 11:00 a.m. EDT.
The live webcast of this presentation will be available to all
interested parties through the PDL website at http://www.pdl.com. Please connect
to this website at least 15 minutes prior to the live webcast to allow time
for any software download that may be needed to hear the webcast. A replay
will be available at http://www.pdl.com starting approximately two hours after
completion of the live webcast, and will remain available for 30 days
thereafter.
About PDL BioPharma
PDL BioPharma, Inc. is a biopharmaceutical company focused on
discovering, developing and commercializing innovative therapies for severe
or life-threatening illnesses. The company currently markets and sells a
portfolio of leading products in the acute-care hospital setting in the
United States and Canada and generates royalties through licensing
agreements with top-tier biotechnology and pharmaceutical companies based
on its pioneering antibody humanization technology. Currently, PDL's
diverse product pipeline includes investigational compounds in Phase 2 or
Phase 3 clinical development for inflammation and autoimmune diseases,
cardiovascular disorders and cancer. The company's research platform is
focused on the discovery and development of antibodies for the treatment of
cancer and autoimmune diseases. For more information, please see PDL's
website at http://www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered
trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
 back to top
Related links:
http://www.pdl.com
CONTACT:
Ami Knoefler, Corporate and Investor
Relations, +1-510-284-8851, or ami.knoefler@pdl.com
|
